KalVista Pharmaceuticals, Inc. (KALV)
16.24
-0.04
(-0.25%)
USD |
NASDAQ |
Mar 02, 15:45
KalVista Pharmaceuticals Research and Development Expense (TTM) : 55.64M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 164.74M |
| Modular Medical, Inc. | 18.51M |
| Iovance Biotherapeutics, Inc. | 302.62M |
| Plus Therapeutics, Inc. | 7.624M |
| BioStem Technologies, Inc. | 6.878M |